Home > Insider Trading > Filing (0001179110-18-000781)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276243	Steven Marc Hanover	175 Toyota Plaza 7Th Floor Memphis TN 38103	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-01-05	1,681	$12.02	129,990	No	4	S	Direct
Common Stock	Disposition	2018-01-05	5,628	$11.13	124,362	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	35,287	Indirect	By Limited Liability Company
Common Stock	6,200	Indirect	By Trust
Common Stock	6,200	Indirect	By Trust

Footnotes

Shares sold to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.61 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.81 to $11.60, inclusive.